Cargando…
Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention
Recent translational studies highlighted the inhibition of transforming growth factor (TGF)-β signaling as a promising target to treat pulmonary arterial hypertension (PAH). However, it remains unclear whether alterations in TGF-β signaling are consistent between PAH patients and animal models. Ther...
Autores principales: | Sanada, Takayuki Jujo, Sun, Xiao-Qing, Happé, Chris, Guignabert, Christophe, Tu, Ly, Schalij, Ingrid, Bogaard, Harm-Jan, Goumans, Marie-José, Kurakula, Kondababu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825543/ https://www.ncbi.nlm.nih.gov/pubmed/33419137 http://dx.doi.org/10.3390/cells10010084 |
Ejemplares similares
-
The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient
por: Happé, Chris, et al.
Publicado: (2020) -
TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family
por: Rol, Nina, et al.
Publicado: (2018) -
Imaging the TGFβ type I receptor in pulmonary arterial hypertension
por: Rotteveel, Lonneke, et al.
Publicado: (2023) -
Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling
por: Kurakula, Kondababu, et al.
Publicado: (2015) -
Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling
por: Kurakula, Kondababu, et al.
Publicado: (2021)